AU3098489A - Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations - Google Patents

Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations

Info

Publication number
AU3098489A
AU3098489A AU30984/89A AU3098489A AU3098489A AU 3098489 A AU3098489 A AU 3098489A AU 30984/89 A AU30984/89 A AU 30984/89A AU 3098489 A AU3098489 A AU 3098489A AU 3098489 A AU3098489 A AU 3098489A
Authority
AU
Australia
Prior art keywords
sufotidine
inflammations
treatment
inflammatory agents
steroidal anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30984/89A
Other languages
English (en)
Inventor
Keith Thomas Bunce
Roger Stables
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3098489A publication Critical patent/AU3098489A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AU30984/89A 1988-03-04 1989-03-03 Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations Abandoned AU3098489A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments
GB8805268 1988-03-04

Publications (1)

Publication Number Publication Date
AU3098489A true AU3098489A (en) 1989-09-07

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30984/89A Abandoned AU3098489A (en) 1988-03-04 1989-03-03 Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations

Country Status (12)

Country Link
JP (1) JP2834175B2 (da)
KR (1) KR890014110A (da)
AU (1) AU3098489A (da)
BE (1) BE1002256A3 (da)
DE (1) DE3906884A1 (da)
DK (1) DK104489A (da)
FR (1) FR2627985A1 (da)
GB (2) GB8805268D0 (da)
IT (1) IT8947714A0 (da)
NL (1) NL8900525A (da)
SE (1) SE8900752L (da)
ZA (1) ZA891640B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
JP2003510263A (ja) * 1999-09-24 2003-03-18 アルコン，インコーポレイテッド シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
SE8900752L (sv) 1989-09-05
DK104489A (da) 1989-09-05
ZA891640B (en) 1990-03-28
GB8904879D0 (en) 1989-04-12
FR2627985A1 (fr) 1989-09-08
GB8805268D0 (en) 1988-04-07
DE3906884A1 (de) 1989-09-14
BE1002256A3 (fr) 1990-11-06
GB2216413A (en) 1989-10-11
JPH01316319A (ja) 1989-12-21
SE8900752D0 (sv) 1989-03-03
DK104489D0 (da) 1989-03-03
KR890014110A (ko) 1989-10-21
JP2834175B2 (ja) 1998-12-09
NL8900525A (nl) 1989-10-02
IT8947714A0 (it) 1989-03-03

Similar Documents

Publication Publication Date Title
AU8583391A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU4211193A (en) New carbohydrate-based anti-inflammatory agents
EP0249561A3 (en) Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU585739B2 (en) Anti-inflammatory and analgesic tape for external use
AU1858292A (en) Intermediates and process for the preparation of new substituted azetidinones as anti-inflammatory and antidegenerative agents
AU8130191A (en) Intermediates in the preparation of heterocyclic-alkylene quinoxalinyloxyphenoxypropanoate herbicides
AU6885787A (en) Anti-inflammatory compounds for opthalmic use
EP0350036A3 (en) Topical hematoporphyrin
AU2655097A (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
AU590640B2 (en) Dementia-improving and therapeutic agents
AU5587594A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
AU7543887A (en) Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU3098489A (en) Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations
GB2219798B (en) Anti-inflammatory 2-arylalkyl-pyridine derivatives
AU5802894A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU4581089A (en) N-substituted 2-cyano-3-oxo-3-substituted-proprionamides as anti-inflammatory agents
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU8027591A (en) Improvements in non-steroidal anti-inflammatory therapy
ZA854947B (en) Beta-lactam derivatives as anti-inflammatory and anti-degenerative agents
AU5371694A (en) Use of the tarchonanthus camphoratus
AU3239393A (en) Fluorenyl derivatives and their use as anti-inflammatory agents
FI933307L (fi) Anti-inflammatoriska indolinyl-n-hydroxiurea- och indolinyl-n-hydroxamsyraderivat
HK1000213A1 (en) Formation of holes in the ground
AU2632088A (en) Improvements in the inhibition of lice